MacroGenics Announces Date of Second Quarter 2021 Financial Results Conference Call
22 juil. 2021 16h05 HE
|
MacroGenics, Inc.
ROCKVILLE, MD, July 22, 2021 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on developing and commercializing innovative monoclonal antibody-based...
MacroGenics and Zai Lab Enter Into Broad Strategic Collaboration to Develop and Commercialize Preclinical Bispecific Antibodies in Oncology
16 juin 2021 07h30 HE
|
MacroGenics, Inc.
Zai Lab granted combination of regional Asian and global rights for up to four CD3- or CD47-based bispecific moleculesMacroGenics provides rights to Zai Lab for its DART® and TRIDENT® multi-specific...
MacroGenics Announces Preliminary Clinical Results from Phase 1 Study of MGC018 to be Presented at ASCO Annual Meeting
19 mai 2021 17h05 HE
|
MacroGenics, Inc.
Dose escalation: anti-tumor activity observed in melanoma (including one confirmed partial response) and in mCRPC patientsCohort expansion in mCRPC: 11/22 (50%) patients have ≥ 50% PSA reduction;...
MacroGenics to Participate in Upcoming Investor Conference
19 mai 2021 07h00 HE
|
MacroGenics, Inc.
ROCKVILLE, MD, May 19, 2021 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a biopharmaceutical company focused on developing and commercializing innovative monoclonal antibody-based...
Zenas BioPharma anuncia nuevos nombramientos de liderazgo ejecutivo
03 mai 2021 05h00 HE
|
Zenas BioPharma
Hua Mu, MD, Ph.D. nombrado presidente, director ejecutivo y director médico interino Joe Farmer nombrado director de negocios HONG KONG y BOSTON, May 03, 2021 (GLOBE NEWSWIRE) -- Zenas BioPharma...
Zenas BioPharma Mengumumkan Pelantikan Kepimpinan Eksekutif Baharu
03 mai 2021 05h00 HE
|
Zenas BioPharma
Hua Mu, MD, Ph.D. Presiden yang dilantik, CEO dan Pemangku CMO Joe Farmer, CBO yang dilantik HONG KONG dan BOSTON, May 03, 2021 (GLOBE NEWSWIRE) -- Zenas BioPharma (“Zenas”), sebuah syarikat...
Zenas BioPharma, 신규 경영진 영입 발표
03 mai 2021 05h00 HE
|
Zenas BioPharma
Hua Mu (MD, Ph.D.) 사장 겸 최고경영책임자 및 최고의학책임자 직무대행으로 선임 Joe Farmer를 최고사업개발책임자로 선임 홍콩/미국 보스턴, May 03, 2021 (GLOBE NEWSWIRE) -- 크로스보더 (중국과 미국 소재) 바이오 제약사로 면역기반 치료제 개발 및 공급에 중점을 두고 있는 Zenas BioPharma...
Zenas BioPharma annonce de nouvelles nominations dans son équipe de haute direction
03 mai 2021 05h00 HE
|
Zenas BioPharma
Hua Mu, MD, Ph.D. nommé président-directeur général et directeur médical par intérim Joe Farmer nommé directeur commercial HONG KONG et BOSTON, 03 mai 2021 (GLOBE NEWSWIRE) -- Zenas BioPharma...
Zenas BioPharma宣布任命新任高管
03 mai 2021 05h00 HE
|
Zenas BioPharma
牟骅博士被任命为总裁、首席执行官兼代理首席医疗官 Joe Farmer被任命为首席商务官 香港和波士顿, May 03, 2021 (GLOBE NEWSWIRE) -- 致力于开发和提供免疫疗法的跨国（中国-美国）生物制药公司Zenas BioPharma（以下称“Zenas”）今天宣布，任命牟骅博士为总裁兼首席执行官及代理首席医疗官，任命Joe Farmer为首席商务和行政官。 ...
Zenas BioPharma Announces New Executive Leadership Appointments
03 mai 2021 05h00 HE
|
Zenas BioPharma
Hua Mu, MD, Ph.D. appointed President, CEO and Acting CMO Joe Farmer appointed CBO HONG KONG and BOSTON, May 03, 2021 (GLOBE NEWSWIRE) -- Zenas BioPharma (“Zenas”), a cross-border (China-USA...